Ulster Business

| 8.9°C Belfast

Ones to Watch: Dr Roisin Molloy, TriMedika

Close

Roisin Molloy

Roisin Molloy

Roisin Molloy

What does your company do and what role do you play?

TriMedika Ltd is company which designs, develops, manufactures and distributes innovative medical devices to hospitals all over the world. Our first device to market is Tritemp, a non-contact, medical grade thermometer, available to healthcare professionals, to deliver greater efficiencies that will benefit patients, by reducing infection spread, lowering costs and eliminating plastic waste in hospitals.

How did the business start and how has it grown?

More than five years ago while working in hospitals, we recognised an opportunity to bring improvements to reduce hospital spend by eliminating single use plastics for routine devices. Feedback from nurses revealed that disposal of bags of plastic waste from ‘used’ thermometer covers represented a significant infection risk as thousands are used in hospitals every day. Nurses reported finding ‘used’ plastics in patients’ beds, food trays and other hazards such as dementia patients swallowing them, which could be fatal.

As 80% of hospital infections are spread through contact, the solution was a medical-grade thermometer that was non-contact and required no plastic covers which would reduce costs, infection risk and eliminate plastic waste. We fast tracked this idea to a market ready, CE marked device in 2017 which is now on NHS frameworks across the UK and used in hospitals and clinics in over 21 countries.

What is your background?

TriMedika has three founders. Dr Roisin Molloy, is chief executive and a biochemist with over 25 years’ experience in product research & development, sales and marketing of medical products into international hospital markets.

Julie Brien, chief operating officer was an export sales and distributor manager for leading NI manufacturers and start-ups.

Paul Molloy, chief financial officer, has around 20 years in financial management providing and implementing finance solutions aligned to organisational strategic business goals of a FTSE 100 company.

What do you do differently from your competition and what are your strengths?

TriMedika is passionate about developing smart, innovative medical devices from hospital healthcare teams’ feedback to deliver better patient care. New technology should challenge current hospital workflows and deliver savings on time, cost and most importantly today – eliminate infection spread in our hospitals.

Who are your main customers?

Our main customers are hospitals and clinics all over the world and the end users are predominantly nurses and doctors delivering frontline medical treatment to patients.

Do you have a target in mind in terms of where you want the business to grow?

Product development is a focus and our first prototypes are already in early trials for our ‘connected’ thermometer which will enable transfer of the data into the patient electronic record. Connected health solutions will benefit not just hospitals, but people at home who’ll be able to monitor their conditions without the upheaval of going to hospital.

What challenges have you faced?

Establishing credibility has been the biggest challenge in a market sector that does not embrace change. However we approached this with every confidence in our device’s superior design, technology and application, and proven through clinical trial comparisons in hospitals.

Who most inspires you?

Technology. As it can overcome any problem and it is in determining the question that we will find the solution.

Where do you see yourself in the next few years?

Building TriMedika with the team – continuing to invest in and develop our people and processes to make a world class organisation that will make a difference to medical technology, bettering patient experience and eliminating plastic waste from our hospitals and environment.

Ulster Business


Privacy